Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Jie Lian

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.4143/crt.2020.330↗
  2. Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer. Co-author DOI 10.7150/jca.48536↗
  3. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer. Co-author DOI 10.1042/cs20180816↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lin Fang · 3 shared papers, 2019–2021 · strength 0.30
  2. Yanqiao Zhang · 3 shared papers, 2019–2021 · strength 0.30
  3. Changjie Lou · 2 shared papers, 2019–2021 · strength 0.19
  4. Zhiwei Li · 2 shared papers, 2019–2021 · strength 0.19
  5. Chao Liu · 1 shared paper, 2020 · strength 0.11
  6. Dan Su · 1 shared paper, 2020 · strength 0.11
  7. Dan Wang · 1 shared paper, 2021 · strength 0.11
  8. Yang Yao · 1 shared paper, 2021 · strength 0.11
  9. Chao Liu · 1 shared paper, 2019 · strength 0.08
  10. Qi Zhao · 1 shared paper, 2019 · strength 0.08
  11. Jiaqi Shi · 1 shared paper, 2019 · strength 0.08
  12. Zengxun Li · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.